Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 17/20 | 0.73 |
| ▸ | HDAC6 | Q9UBN7 | 15/20 | 0.73 |
| ▸ | HDAC2 | Q92769 | 14/20 | 0.73 |
| ▸ | HDAC3 | O15379 | 13/20 | 0.73 |
| ▸ | HDAC4 | P56524 | 12/20 | 0.73 |
| ▸ | HDAC7 | Q8WUI4 | 12/20 | 0.73 |
| ▸ | HDAC10 | Q969S8 | 12/20 | 0.73 |
| ▸ | HDAC11 | Q96DB2 | 12/20 | 0.73 |
| ▸ | HDAC8 | Q9BY41 | 12/20 | 0.73 |
| ▸ | HDAC9 | Q9UKV0 | 12/20 | 0.73 |
| ▸ | HDAC5 | Q9UQL6 | 12/20 | 0.73 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7366594 | 0.88 | HDAC1 (0.68) | HDAC1HDAC6HDAC2HDAC3HDAC4 | |
| SCHEMBL4581162 | 0.87 | HDAC6 (0.73) | HDAC1HDAC6HDAC2HDAC3HDAC4 | |
| SCHEMBL1067946 | 0.84 | HDAC6 (0.81) | HDAC1HDAC6HDAC2HDAC3HDAC4 | |
| SCHEMBL7367671 | 0.83 | HDAC6 (0.61) | HDAC1HDAC6HDAC2HDAC3HDAC4 | |
| SCHEMBL6037980 | 0.82 | HDAC6 (0.74) | HDAC1HDAC6HDAC2HDAC3HDAC4 | |
| SCHEMBL6037928 | 0.82 | HDAC6 (0.79) | HDAC1HDAC6HDAC2HDAC3HDAC4 | |
| SCHEMBL6037929 | 0.82 | HDAC6 (0.79) | HDAC1HDAC6HDAC2HDAC3HDAC4 | |
| SCHEMBL6386310 | 0.82 | HDAC6 (1.00) | HDAC1HDAC6HDAC2HDAC3HDAC4 | |
| SCHEMBL5460436 | 0.81 | HDAC6 (0.77) | HDAC1HDAC6HDAC2HDAC3HDAC4 | |
| SCHEMBL6038355 | 0.80 | HDAC6 (0.75) | HDAC1HDAC6HDAC2HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020103192-A1 | Inhibitors of histone deacetylase | ABBOTT LABORATORIES | 2002-08-01 | — | — | US | claimed |
| US-20020177594-A1 | Inhibitors of histone deacetylase | ABBOTT LABORATORIES | 2002-11-28 | — | — | US | disclosed |
| US-20020103192-A1 | Inhibitors of histone deacetylase | ABBOTT LABORATORIES | 2002-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020103192-A1 | Inhibitors of histone deacetylase | HDAC1, HDAC5, HDAC4 | HDAC1 1/4885HDAC6 11/4885HDAC2 7/4885 |
| US-20020177594-A1 | Inhibitors of histone deacetylase | HDAC1, HDAC11, HDAC3 | HDAC1 1/4885HDAC6 7/4885HDAC2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.